Oppenheimer analyst Mohan Naidu maintained a Hold rating on CPSI (CPSI) today. The company’s shares opened today at $30.
Naidu wrote:
“CPSI reported 4Q revs/EPS of $72.3M/$0.78 vs. consensus $74.1M/$0.58E. Revs declined y/y on a tough MU3 comp, while the EPS beat came from a one-time tax benefit. 4Q bookings rose 19% y/y and 25% sequentially on continued TruBridge strength (+6% seq, +41% y/y), though total bookings were down 19% y/y in CY18. Given the bookings decline, we trimmed our CY19E revs by $11M to $283M, while our CY19E Adj. EPS rose from $2.26 to $2.72 on $10M cost synergies expected in 2019. We’re encouraged by 28-30 net new installs expected in 2019 (bracketing 2018’s 29), amid physician dissatisfaction with existing offerings, traction in CPSI’s nTrust (SaaS) offering and continued TruBridge strength.”
According to TipRanks.com, Naidu is a 5-star analyst with an average return of 10.9% and a 55.6% success rate. Naidu covers the Services sector, focusing on stocks such as Tivity Health Inc, Evolent Health, and Premier Inc.
Currently, the analyst consensus on CPSI is a Hold with an average price target of $28.
See today’s analyst top recommended stocks >>
The company has a one-year high of $34.65 and a one-year low of $23.81. Currently, CPSI has an average volume of 121.4K.
Based on the recent corporate insider activity of 39 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Computer Programs & Systems, Inc. engages in the provision of healthcare information technology solutions and services. It operates through the following segments: Acute Care EHR, Post-acute Care EHR, and TruBridge. The Acute EHR segment consists of acute care software solutions and support generated by Evident and Healthand.
